A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Ramji, Alnoor ^{[3
]}

Fung, Scott ^{[4
]}

Ahn, Sang Hoon ^{[5
]}

Chuang, Wan-Long ^{[6
]}

Yoon, Seung Kew ^{[7
]}

Kao, Jia-Horng ^{[8
]}

Chen, Chi-Yi ^{[9
]}

Tam, Edward ^{[10
]}

Khalili, Mandana ^{[11
]}

Bae, Ho ^{[12
]}

Ma, Xiaoli ^{[13
]}

Tak, Won Young ^{[14
]}

Flaherty, John F. ^{[15
]}

Gaggar, Anuj ^{[15
]}

Suri, Vithika ^{[15
]}

Tan, Susanna ^{[15
]}

Liu, Yang ^{[15
]}

Wu, George ^{[15
]}

Subramanian, Mani ^{[15
]}

Hann, Hie-Won ^{[16
]}

Agarwal, Kosh ^{[17
]}

Lim, Young-Suk ^{[18
,19
]}

Chan, Henry ^{[19
,20
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[2] Hosp Gen Univ Valle Hebron & Ciberehd, Barcelona, Spain

[3] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada

[4] Toronto Gen Hosp, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[5] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea

[6] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea

[8] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan

[9] Chia Yi Christian Hosp, Chiayi, Taiwan

[10] LAIR Ctr, Vancouver, BC, Canada

[11] Univ Calif San Francisco, San Francisco, CA 94143 USA

[12] St Vincents Med Ctr, Los Angeles, CA USA

[13] Drexel Univ, Coll Med, Philadelphia, PA USA

[14] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[15] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[16] Thomas Jefferson Univ Hosp, Div Gastroenterol & Hepatol, Philadelphia, PA USA

[17] Kings Coll Hosp London, Inst Liver Studies, London, England

[18] Univ Ulsan, Ctr Liver, Asan Med Ctr, Dept Gastroenterol,Coll Med, Ulsan, South Korea

[19] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China

[20] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AS091

引用

页码：S67 / S68

页数：2

共 50 条

[21] IMPACT OF PRIOR TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT DURATION ON TENOFOVIR ALAFENAMIDE (TAF) SAFETY PROFILE IN VIRALLY SUPPRESSED CHRONIC HBV PATIENTS SWITCHED FROM TDF TO TAF
Chan, Henry Lik Yuen
Lampertico, Pietro
Ahn, Sang Hoon
Fung, Scott
Bae, Ho
Ramji, Alnoor
Lee, Jung Sung
Shafran, Stephen
Gordon, Stuart
Phan, Charles
Tan, Susanna
Flaherty, John
Gaggar, Anuj
Wu, George
Suri, Vithika
Lau, Daryl
Byun, Kwan Soo
Agarwal, Kosh
Lim, Young-Suk
Buti, Maria
GUT, 2020, 69 : A74 - A75
[22] IMPACT OF COADMINISTRATION WITHOUT OR WITH FOOD ON THE 96-WEEK EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HBV PATIENTS SWITCHED FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TAF
Kao, Jia-Horng
Chuang, Wan-Long
Chen, Chi-Yi
Ahn, Sang Hoon
Fung, Scott K.
Elkhashab, Magdy
Hann, Hie-Won L.
Ravendhran, Natarajan
Nguyen, Tuan T.
Tan, Susanna
Flaherty, John F.
Gagger, Anuj
Gao, Bing
Brainard, Diana M.
Phan, Charles G.
Lim, Young-Suk
Ferret, Maria Asuncion Buti
Lampertico, Pietro
HEPATOLOGY, 2020, 72 : 484A - 484A
[23] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) AND/OR OTHER ORAL ANTIVIRALS (OAVS) TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: FINAL 2-YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 2
Lim, Young-Suk
Lin, Chun-Yen
Heo, Jeong
Bae, Ho
Chuang, Wan-Long
Yin, Tak
Tsang, Owen
Fournier, Claire
Hui, Aric Josun
Trinh, Huy
Chan, Carol Yee Kwan
Tan, Susanna K.
Zhao, Yang
Flaherty, John F.
Suri, Vithika
Gaggar, Anuj
Brainard, Dianna M.
Ryder, Stephen
La Janssen, Harry
GUT, 2021, 70 : A77 - A77
[24] 1 YEAR SAFETY AND EFFICACY DATA IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TENOFOVIR DISOPROXIL FUMARATE (TDF) AFTER SWITCHING FROM TDF TO TENOFOVIR ALAFENAMIDE (TAF)
Pan, Calvin Q.
Gane, Edward
Seto, Wai-Kay
Janssen, Harry L.
Caruntu, Florin
Kim, Hyung Joon
Abdurakhmanov, Dzhamal
Nishiguchi, Shuhei
Bae, Ho
Mo, Shuyuan
Suri, Vithika
Gaggar, Anuj
Flaherty, John F.
Kao, Jia-Horng
Brunetto, Maurizia Rossana
Buti, Maria
GASTROENTEROLOGY, 2018, 154 (06) : S1132 - S1133
[25] Safety and efficacy at 1 year after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide in patients with chronic hepatitis B and risk factors for TDF use
Gane, E.
Seto, W. K.
Janssen, H.
Caruntu, F. A.
Kim, H. J.
Abdurakhmanov, D.
Nishiguchi, S.
Andrzej, H.
Bae, H.
Mo, S.
Suri, V.
Gaggar, A.
Flaherty, J. F.
Kao, J-H
Brunetto, M.
Buti Ferret, M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 42 - 43
[26] TENOFOVIR ALAFENAMIDE (TAF) COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) IN PATIENTS WITH CHRONIC HBV: WEEK 96 EFFICACY AND SAFETY RESULTS IN CHINESE PATIENTS ENROLLED IN 2 GLOBAL PHASE 3 STUDIES
Chan, Henry Lik-Yuen
Seto, Wai Kay
Fung, Scott
Hou, Jinlin
Pan, Calvin
Chuang, Wan-Long
Chang, Ting-Tsung
Hui, Aric-Josun
Chen, Chi-Yi
Tsang, Tak Yin Owen
Yang, Jenny
Flaherty, John
Gaggar, Anuj
Mo, Shuyuan
Kao, Jia-Horng
GUT, 2018, 67 : A302 - A302
[27] SAFETY AND EFFICACY AT 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TDF USE
Buti, Maria
Lampertico, Pietro
Lim, Young-Suk
Agarwal, Kosh
Fung, Scott K.
Tsang, Owen
Elkhashab, Magdy
Kao, Jia-Horng
Luis Calleja, Jose
Khalili, Mandana
Ravendhran, Natarajan
Tan, Susanna
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Wu, George
Hann, Hie-Won L.
Pan, Calvin
Kim, Hyung Joon
Kennedy, Patrick T. F.
Chan, Henry Lik Yuen
HEPATOLOGY, 2019, 70 : 301A - 301A
[28] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
Nam, Heechul
Han, Ji Won
Lee, Soon Kyu
Yang, Hyun
Lee, Hae Lim
Sung, Pil Soo
Song, Myeong Jun
Kwon, Jung Hyun
Jang, Jeong Won
Chang, U-Im
Kim, Chang Wook
Nam, Soon Woo
Bae, Si Hyun
Choi, Jong Young
Yoon, Seung Kew
Yang, Jin Mo
Kim, Hee Yeon
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1673 - 1683
[29] Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study
Lok, James
Veloz, Maria Fernanda Guerra
Byrne, Ruth
Carey, Ivana
Childs, Kate
Agarwal, Kosh
Nelson, Mark
CLINICAL THERAPEUTICS, 2024, 46 (02) : 159 - 163
[30] A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96
Brunetto, M.
Lim, Y. S.
Gane, E.
Seto, W. K.
Osipenko, M.
Ahn, S. H.
Janssen, H. L.
Shukla, A.
Chuang, W. L.
Trinh, H.
Celen, M. K.
Flaherty, J. F.
Lau, A. H.
Gaggar, A.
Suri, V.
Bhardwaj, N.
Kim, K.
Subramanian, G. M.
Pan, C.
Izumi, N.
Marcellin, P.
Chan, H.
Buti, M.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S25 - S26

← 1 2 3 4 5 →